Log in

Relevant bibliographies by topics / Laboratory trial / Books

To see the other types of publications on this topic, follow the link: Laboratory trial.

Books on the topic 'Laboratory trial'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Laboratory trial.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Masser, Ian. The Regional Research Laboratory initiative: The experience of the trial phase March 1988. Economic and Social Research Council, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

1944-, Geller Nancy L., ed. Advances in clinical trial biostatistics. Marcel Dekker, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

V, Kabanov Alexander, Felgner Philip L. 1950-, and Seymour L. W, eds. Self-assembling complexes for gene delivery: From laboratory to clinical trial. Wiley, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Lappage, J. Evaluation of the Wronz pile thickness probe by an inter-laboratory trial. Wronz, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Burling-Claridge, G. R. Inter-laboratory trial of the Draft New Zealand Standard (DZ8716) [ie DZ8719]: Method for the measurement of the fibre length of scoured wool after carding. Wronz, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lelia, Duley, and Farrell Barbara 1946-, eds. Clinical trials. BMJ Books, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Franklin, R. E. Fast track concrete paving: Laboratory and full-scale trials in United Kingdom. Highways Resource Centre, Transport and Road Research Laboratory, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Mark, Chang, ed. Adaptive design methods in clinical trials. 2nd ed. Taylor & Francis, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

United States. General Accounting Office., ed. PROTEST OF VA REJECTION OF BID FOR DRUG TRAIL LABORATORY... B-265956, 155202... U.S. GAO... SEPTEMBER 14, 1995. s.n., 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Simon, Day. Dictionary for Clinical Trials. John Wiley & Sons, Ltd., 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Ouvrier, Ashley. Faire de la recherche médicale en Afrique: Ethnographie d'un village-laboratoire sénégalais. Éditions Karthala, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

European Court of Human Rights. Affaire Darnell c. Royaume-uni : arrêt du 26 Octobre 1993 =: Case of Darnell v. the United Kingdom : judgment of 26 October 1993. Greffe de la Cour, Conseil de l'Europe, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Chang, Mark. Adaptive design theory and implementation using SAS and R. CRC Press, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Reynolds. Preclinical Trial Design: A Guide to Best Practice in Animal-Based Research. Wiley & Sons, Limited, John, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Geller, Nancy L. Advances in Clinical Trial Biostatistics. Taylor & Francis Group, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Geller, Nancy L. Advances in Clinical Trial Biostatistics. Taylor & Francis Group, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

The Metropolitan Laboratory Magazine, Vol. 1: Education: Trial and Error. Spector Books, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Geller, Nancy L. Advances in Clinical Trial Biostatistics. Taylor & Francis Group, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Geller, Nancy L. Advances in Clinical Trial Biostatistics. Taylor & Francis Group, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Geller, Nancy L. Advances in Clinical Trial Biostatistics. Taylor & Francis Group, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Felgner, Philip L., and Leonard W. Seymour. Self-Assembling Complexes for Gene Delivery: From Laboratory to Clinical Trial. John Wiley & Sons, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Felgner, Philip L., Leonard W. Seymour, and Alexander V. Kabanov. Self-Assembling Complexes for Gene Delivery: From Laboratory to Clinical Trial. Wiley & Sons, Incorporated, John, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Carder, D. R. Laboratory Trial Mixes for Lime-stabilised Soil Columns and Lime Piles (TRL 306). Thomas Telford Ltd, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Government, U. S., and Los Alamos Scientific Laboratory. Los Alamos: Beginning of an Era, 1943-1945, Covering Military and Scientific Realities, Designing the Bomb, Trinity, Trial Run, Fission Bombs, H-Bomb, and Thermonuclear Program History. Independently Published, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Ogg, Graham. Practical Guide to Quality Management in Clinical Trial Research. Taylor & Francis Group, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ogg, Graham. Practical Guide to Quality Management in Clinical Trial Research. Taylor & Francis Group, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

A Practical Guide to Quality Management in Clinical Trial Research. Informa Healthcare, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Cummings, Jeffrey, Jefferson Kinney, and Howard Fillit, eds. Alzheimer's Disease Drug Development. Cambridge University Press, 2022. http://dx.doi.org/10.1017/9781108975759.

Full text

Abstract:

Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clin

APA, Harvard, Vancouver, ISO, and other styles

29

Day, Simon. Dictionary for Clinical Trials. Wiley & Sons, Incorporated, John, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Day, Simon. Dictionary for Clinical Trials. Wiley & Sons, Incorporated, John, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Day, Simon. Dictionary for Clinical Trials. Wiley & Sons, Incorporated, John, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Day, Simon. Dictionary for Clinical Trials. Wiley & Sons, Incorporated, John, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Duley, Leila, and Barbara Farrell. Clinical Trials. Wiley & Sons, Incorporated, John, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

N. M, Gayathri, and Nidhi R. THE LAW RELATING TO CLINICAL TRIALS IN INDIA: THE PREVAILING DEFICIENCIES AND THE ROAD AHEAD. Jupiter Publications Consortium, 2023. http://dx.doi.org/10.47715/jpc.b.978-93-91303-78-5.

Full text

Abstract:

Clinical trials stand at the crux of medical advancement, serving as the vital link between laboratory research and the availability of new treatments for patients’ ailments. In a world increasingly reliant on evidence-based medicine, the importance of rigorous, ethical, and well-regulated clinical trials cannot be overstated. However, the dynamic and multifaceted nature of clinical trials raises complex legal, ethical, and social issues, particularly in a diverse and populous nation like India. This book, “The Law Relating to Clinical Trials in India: The Prevailing Deficiencies and the Road

APA, Harvard, Vancouver, ISO, and other styles

35

Keshav, Satish, and Alexandra Kent. Chronic diarrhoea. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0029.

Full text

Abstract:

Four to five per cent of the Western population suffers from chronic diarrhoea (defined as the passage of >3 stools per day, for >4 weeks), with irritable bowel syndrome (IBS) being the commonest cause in 20–40-year-old patients. It is the commonest reason for referral to secondary care gastroenterology clinics. The list of possible causes of chronic diarrhoea is long but, in the absence of rectal bleeding, loss of weight, or abnormal blood tests, it is unlikely to be due to a serious illness. Laboratory investigations should include serum glucose, electrolytes, renal and liver tests, fu

APA, Harvard, Vancouver, ISO, and other styles

36

Rider, Lisa G., and Frederick W. Miller. Outcome assessment in the idiopathic inflammatory myopathies. Edited by Hector Chinoy and Robert Cooper. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198754121.003.0016.

Full text

Abstract:

Due to their rarity, heterogeneity, and multispecialty nature, the myositis syndromes have limited data-driven consensus on appropriate outcome measures. Recently, two international, multispecialty consortia developed new tools and consensus on core set measures of myositis disease activity and damage, as well as response criteria that are now recommended for use as clinical trial endpoints but will also be useful in clinical practice. Magnetic resonance imaging, muscle ultrasound, selected laboratory tests, and immunological biomarkers—including cytokines, chemokines, lymphocyte flow cytometr

APA, Harvard, Vancouver, ISO, and other styles

37

A Manager's Guide to the Design and Conduct of Clinical Trials (Manager's Guide Series). Wiley-Liss, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Biggar, Patrick, Hansjörg Rothe, and Markus Ketteler. Epidemiology of calcium, phosphate, and parathyroid hormone disturbances in chronic kidney disease. Edited by David J. Goldsmith. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0109_update_001.

Full text

Abstract:

Chronic kidney disease-mineral and bone disorders (CKD-MBD), calcium, phosphate, and parathyroid hormone are biomarkers of mortality and cardiovascular risk. Hyperphosphataemia is a prominent and pathophysiologically most plausible risk indicator. Calcium balance and load appear to be more important than serum concentrations. Parathyroid hormone is a less reliable marker with a relatively wide range extending above that applicable for a normal population especially when used as a singular laboratory parameter without additional assessment of bone metabolism, for example, bone-specific alkaline

APA, Harvard, Vancouver, ISO, and other styles

39

Randomized clinical trials of nonpharmacologic treatments. Chapman and Hall/CRC, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Williams, ER, AC Matheson, and CE Harwood. Experimental Design and Analysis for Tree Improvement. CSIRO Publishing, 2002. http://dx.doi.org/10.1071/9780643090132.

Full text

Abstract:

Experimental Design and Analysis for Tree Improvement provides a set of practical procedures to follow when planning, designing and analysing tree improvement trials.  Using many fully-worked examples, it outlines how to: design field, glasshouse and laboratory trials; efficiently collect data and construct electronic data files; pre-process data, screening for data quality and outliers; analyse data from single and across-site trials using either GenStat or SAS; and interpret the results from statistical analyses. The authors address the many practical issues often faced in forest

APA, Harvard, Vancouver, ISO, and other styles

41

Chinoy, Hector, and Robert G. Cooper, eds. Myositis (Oxford Rheumatology Library). Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198754121.001.0001.

Full text

Abstract:

Myositis, or the idiopathic inflammatory myopathies (IMM) are a group of rare autoimmune diseases of considerable health significance. Features include muscle weakness, raised skeletal muscle enzymes, and characteristic histopathological changes. IIM can be split into polymyositis (PM), dermatomyositis (DM), and inclusion body myositis (IBM). If diagnosed promptly PM and DM can be treated with immunosuppression, but IBM currently cannot be treated. Summarizing the current understanding of the epidemiology, genetic and environmental risk factors, and clinical features, this handbook gives pract

APA, Harvard, Vancouver, ISO, and other styles

42

DeMets, David L., Susan Smith Ellenberg, and Thomas R. Fleming. Data Monitoring Committees in Clinical Trials: A Practical Perspective. Wiley & Sons, Incorporated, John, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Good Clinical Laboratory Practice: A Quality System for Laboratories Which Undertake the Analysis of Samples from Clinical Trials. BARQA, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Dictionary for clinical trials. John Wiley & Sons, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Dictionary for clinical trials. 2nd ed. Wiley, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Stowell, Janet, and Ronan Breen. Pulmonary disease caused by non-tuberculous mycobacteria. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199657742.003.0014.

Full text

Abstract:

This chapter describes a case of Mycobacterium malmoense in a male ex-smoker with chronic obstructive pulmonary disease. The approaches to a diagnosis of pulmonary non-tuberculous mycobacterial disease are discussed, including key laboratory features and associated radiological changes. The factors influencing the decision to treat and treatment regimen selected are reviewed, along with evidence from landmark trials regarding drug combinations and the role of surgery in managing non-tuberculous mycobacterial disease. This case was complicated by a secondary diagnosis of invasive aspergillosis,

APA, Harvard, Vancouver, ISO, and other styles

47

Unit 731 - Laboratory of the Devil: Auschwitz of the East. Fonthill Media, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Anselmi, A. C. M., S. C. E. Gallon, P. Müller, and K. Reinhardt. Populationsgröße, Trichterdichte und Habitatpräferenz der Dünen-Ameisenjungfer Myrmeleon bore (Tjeder, 1941) im Gebiet der Dresdner Heide (Neuroptera). Technische Universität Dresden, 2021. http://dx.doi.org/10.25368/2022.402.

Full text

Abstract:

Following the first record of Myrmeleon bore (Tjeder, 1941) in the Dresden Heath area in 2019 (KURTH 2020, Sächs. Entomol. Z. 10: 71-80), the population size and density of the species was determined. M. bore mainly was found in open, sparsely vegetated, sandy areas with direct sunlight exposure. The area-weighted density of the entire study site (4.05 hectares) was 0.177 larvae/m2. Population size estimates based on random quadrat counts lead to a figure of 4000-7000 individuals - the largest known population of this species. The positive correlation between larval size and pit diameter known

APA, Harvard, Vancouver, ISO, and other styles

49

Ackland, Gareth L. Neural and endocrine function in the immune response to critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0310.

Full text

Abstract:

The neurohormonal physiological response to various stressors is pivotal for maintaining homeostasis. However, the advent of modern critical care has distorted evolutionary biology by generating the entirely new (patho)physiological entity of critical illness. By extending the biological features of the ‘fight or flight’ response beyond the acute phase, distinct neurohormonal, and immune profiles have become increasingly apparent. Both direct and off-target effects of neurohormonal control on immune function are implicated in the disruption of bidirectional links between neurohormones and immu

APA, Harvard, Vancouver, ISO, and other styles

50

Todd, Stacy, and Nick Beeching. Fungal infection. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0315.

Full text

Abstract:

Fungi, comprising yeasts, moulds, and higher fungi, have a worldwide distribution and are uncommon causes of disease in healthy individuals. However, over the last 20 years, invasive fungal disease (IFD) has become an increasing cause of morbidity and mortality. This is probably due to the increasing numbers of patients with underlying host conditions, which predispose to opportunistic IFD (e.g. transplant and anti-tumour necrosis factor immunosuppression, HIV, or chronic lung disease), and to increased recognition of endemic IFD (e.g. histoplasmosis), which cause disease in both immunocompete

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!